Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06984250 | Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer(HFCBB) | recruiting | — | 315 | National Taiwan University HospitalOTHER | 1 | May 22, 2025 | clinicaltrials |
| NCT05999396 | FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer(CoRe_CC-3) | recruiting | Phase 1 | 89 | German Cancer Research CenterOTHER | 1 |
| May 21, 2025 |
| clinicaltrials |
| NCT06915857 | Topical Betamethasone Versus Moisturizer in Preventing Radiation Dermatitis in Large-Breasted Patients Treated in the Prone Position | recruiting | Phase 3 | 276 | Sunnybrook Health Sciences CentreOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT06367088 | Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast Cancer | recruiting | Phase 2 | 27 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | May 20, 2025 | clinicaltrials |
| NCT06977893 | Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04) | recruiting | Phase 3 | 194 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | May 18, 2025 | clinicaltrials |
| NCT03201861 | Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women | recruiting | Phase 3 | 762 | RenJi HospitalOTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT04947189 | Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer(4CAST) | recruiting | Phase 1 / Phase 2 | 65 | St Vincent's Hospital, SydneyOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT06165419 | Definitive Radiation for High-Risk Spine Metastases | recruiting | Phase 2 | 26 | Stony Brook UniversityOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT06970288 | Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer Detection | recruiting | — | 85 | Ain Shams UniversityOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT05062707 | Early Ageing During Therapy in AYA Cancer Patients | recruiting | — | 120 | University Medical Center GroningenOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT06902051 | Study on the Use of Lateral Decubitus Position in Left Breast Cancer Patients Undergoing Adjuvant Radiotherapy(LDPLBC) | recruiting | N/A | 86 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | May 11, 2025 | clinicaltrials |
| NCT06962670 | Predicting Cancer Risk With Digital and Molecular Markers(PräDigt) | recruiting | N/A | 1,250 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | May 8, 2025 | clinicaltrials |
| NCT04261244 | NeoRad Breast Cancer Study(NeoRad) | recruiting | Phase 3 | 1,826 | Bielefeld UniversityOTHER | 1 | May 7, 2025 | clinicaltrials |
| NCT06958627 | The Impact of Intelligent Patient Management Model on Medication Adherence of Pyrotinib Compared to Traditional Patient Management Model: a Prospective, Multicenter, Randomized Controlled Clinical Study(any) | recruiting | Phase 2 / Phase 3 | 964 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT05621837 | Quantifying Systemic Immunosuppression to Personalize Cancer Therapy(Serpentine) | recruiting | — | 1,000 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | May 2, 2025 | clinicaltrials |
| NCT05658172 | Standard Surveillance vs. Intensive Surveillance in Early Breast Cancer(SURVIVE) | recruiting | N/A | 3,500 | Prof. Wolfgang JanniOTHER | 1 | May 2, 2025 | clinicaltrials |
| NCT06643585 | A Randomized Secondary Adjuvant Treatment Intervention Study Comparing Trastuzumab-Deruxtecan to SOC Therapy in eBC Patients With Molecular Relapse(SURVIVE HERoes) | recruiting | Phase 3 | 180 | Prof. Wolfgang JanniOTHER | 1 | May 2, 2025 | clinicaltrials |
| NCT04503265 | A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies | recruiting | Phase 1 / Phase 2 | 122 | AtlasMedx, IncorporatedINDUSTRY | 1 | May 1, 2025 | clinicaltrials |
| NCT04625023 | A Master Protocol Empowering Mechanobiology Translation Research in Breast Cancer(METAMECH) | recruiting | — | 1,500 | IFOM ETS - The AIRC Institute of Molecular OncologyOTHER | 1 | May 1, 2025 | clinicaltrials |
| NCT06207734 | Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Breast Cancer | recruiting | Phase 2 | 120 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestOTHER | 1 | May 1, 2025 | clinicaltrials |
| NCT05835570 | Integrin αvβ6-targeted PET in Malignant Tumors | recruiting | — | 200 | Zhongnan HospitalOTHER | 1 | Apr 30, 2025 | clinicaltrials |
| NCT06225284 | Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients(ESCALATE) | recruiting | Phase 2 | 124 | National Taiwan University HospitalOTHER | 1 | Apr 29, 2025 | clinicaltrials |
| NCT06916338 | Clinical Study of 18F-Labeled FAPI-04 in PET Imaging of Breast Cancer | recruiting | — | 30 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Apr 29, 2025 | clinicaltrials |
| NCT03824145 | Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer(EDC) | recruiting | N/A | 176 | Medical College of WisconsinOTHER | 1 | Apr 27, 2025 | clinicaltrials |
| NCT06947330 | Comparison Between Erector Spinae Plane Block Versus Serratus Anterior Plane Block Regarding Analgesia Post Modified Radical Mastectomy(FMASUMD66/2025) | recruiting | Phase 3 | 100 | Kholoud UsamaOTHER | 1 | Apr 27, 2025 | clinicaltrials |
| NCT05535413 | UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases | recruiting | Phase 1 / Phase 2 | 30 | Hunan Cancer HospitalOTHER | 1 | Apr 25, 2025 | clinicaltrials |
| NCT06476119 | OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infiltrating Lymphocytes(OPTImaL) | recruiting | — | 490 | The Netherlands Cancer InstituteOTHER | 1 | Apr 23, 2025 | clinicaltrials |
| NCT06111417 | Use of an Ultra-rapid BRCA1/2 Status Screening Test in Diagnostic and Theranostic Indication: Performance and Interest for Patients and Practitioners(TURBO) | recruiting | — | 150 | Centre Georges Francois LeclercOTHER | 1 | Apr 22, 2025 | clinicaltrials |
| NCT06313983 | A Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast Cancer | recruiting | Phase 3 | 339 | Tianjin Hemay Pharmaceutical Co., LtdINDUSTRY | 1 | Apr 22, 2025 | clinicaltrials |
| NCT06938360 | Clinical Efficacy and Safety Assessment of Breast-Conserving Surgery for Central Breast Cancer: A Prospective Randomized Controlled Trial | recruiting | N/A | 158 | Xijing HospitalOTHER | 1 | Apr 22, 2025 | clinicaltrials |
| NCT06938373 | Development and Application of Accurate Detection Technology Based on Multimodal Data of Breast Cancer Comobid Depression | recruiting | — | 1,000 | Xiangya Hospital of Central South UniversityOTHER | 1 | Apr 22, 2025 | clinicaltrials |
| NCT06777420 | Question Prompt List in Breast Cancer Patients Planned for Neoadjuvant Chemotherapy(QPL) | recruiting | N/A | 218 | Region Örebro CountyOTHER | 1 | Apr 20, 2025 | clinicaltrials |
| NCT05288777 | Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer(Breast53) | recruiting | Phase 2 / Phase 3 | 45 | University of VirginiaOTHER | 1 | Apr 18, 2025 | clinicaltrials |
| NCT04892693 | Talazoparib in Advanced Breast Cancer Patients With Homologous Recombinant Deficiency | recruiting | Phase 2 | 70 | Seoul National University HospitalOTHER | 1 | Apr 17, 2025 | clinicaltrials |
| NCT05536128 | Evaluating the Efficacy and Safety of Fulvestrant Plus DNA Damage Repair Inhibitors After a CDK4/6 Inhibitor(Post-CDK) | recruiting | Phase 2 | 64 | Seoul National University HospitalOTHER | 1 | Apr 17, 2025 | clinicaltrials |
| NCT06931548 | Ways of Retaining the Inframammary Fold in Implant-based Breast Surgery | recruiting | N/A | 100 | Branch Office of "Hadassah Medical Ltd"OTHER | 1 | Apr 17, 2025 | clinicaltrials |
| NCT06928701 | Impact of "Targeted" Nutritional Apport and Exercise on the Modulation of Metabolic and Immune-related Gene Expression Signatures in Early Breast Cancer (eBC) Patients Candidate to Neoadjuvant Therapy (NAT)(NEOMET) | recruiting | N/A | 160 | University of Eastern PiedmontOTHER | 1 | Apr 15, 2025 | clinicaltrials |
| NCT06926543 | Postoperative Radiotherapy in Breast Cancer- Concurrent or Sequential With Chemotherapy(CONCERT) | recruiting | Phase 3 | 858 | Dr. Tabassum WadasadawalaOTHER | 1 | Apr 13, 2025 | clinicaltrials |
| NCT04933266 | Subpectoral Plexus Block With Multi-level TPVB for Surgical Anesthesia During Primary Breast Cancer Surgery | recruiting | N/A | 100 | Chinese University of Hong KongOTHER | 1 | Apr 11, 2025 | clinicaltrials |
| NCT06073106 | Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention(OPTIMA-C) | recruiting | — | 500 | Tan Tock Seng HospitalOTHER | 1 | Apr 11, 2025 | clinicaltrials |
| NCT02992574 | Trial Evaluating Role of Post Mastectomy Radiotherapy in Women With Node Negative Early Breast Cancer(PMRT-NNBC) | recruiting | N/A | 1,022 | Tata Memorial CentreOTHER | 1 | Apr 10, 2025 | clinicaltrials |
| NCT03870620 | Metastatic Breast Cancer in Austria | recruiting | — | 5,000 | Arbeitsgemeinschaft medikamentoese TumortherapieOTHER | 1 | Apr 10, 2025 | clinicaltrials |
| NCT05450016 | Assessment of the Breast Cosmesis Using Deep Neural Networks: an Exploratory Study (ABCD)(ABCD) | recruiting | — | 720 | Tata Memorial CentreOTHER | 1 | Apr 10, 2025 | clinicaltrials |
| NCT06920810 | Viscum Album for TNBC on Adjuvant Pembrolizumab(TNBNOBA) | recruiting | Phase 4 | 40 | Ilsan Cha hospitalOTHER | 1 | Apr 10, 2025 | clinicaltrials |
| NCT01785420 | Pre Operative Trastuzumab in Operable Breast Cancer | recruiting | Phase 3 | 1,100 | Dr Rajendra A. BadweOTHER_GOV | 1 | Apr 9, 2025 | clinicaltrials |
| NCT06918184 | Timing of Specific Exercise Therapy After Breast Cancer Surgery: Early Versus Delayed Initiation(BEST-Timing) | recruiting | N/A | 140 | Al Hayah University In CairoOTHER | 1 | Apr 9, 2025 | clinicaltrials |
| NCT06918262 | Observational Clinical Study on Role of MRD in Predicting Local Therapy in Oligometastatic Breast Cancer | recruiting | — | 40 | The First Hospital of Jilin UniversityOTHER | 1 | Apr 9, 2025 | clinicaltrials |
| NCT05013255 | Pioglitazone Therapy Targeting Fatigue in Breast Cancer | recruiting | Phase 2 | 30 | West Virginia UniversityOTHER | 1 | Apr 8, 2025 | clinicaltrials |
| NCT05406635 | Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer(HER2BIC) | recruiting | N/A | 220 | Odense University HospitalOTHER | 1 | Apr 8, 2025 | clinicaltrials |
| NCT06006806 | Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy | recruiting | N/A | 100 | Covenant Health Cancer CenterOTHER | 1 | Apr 8, 2025 | clinicaltrials |
Data updated 24 days agoSource updated May 22, 2025source: clinicaltrials